Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Occidental Petroleum (OXY)

Occidental previews Q4 2025 factors; OxyChem sale now reported as discontinued operations

Neutral Impact 3 of 5 earnings Written later

Occidental Petroleum released preliminary fourth-quarter 2025 earnings considerations and furnished them as Exhibit 99.1 to an 8-K filed January 20, 2026. The document does not give a fourth-quarter earnings estimate and says the figures are preliminary and subject to finalization, so it does not show whether results improved or declined.

Key points

  • OxyChem sale closed January 2, 2026; its results will be reported as discontinued operations, starting with the 2025 Form 10-K.
  • Expected fourth-quarter 2025 adjusted effective tax rate: 35% to 37% for continuing operations and 24% to 26% for discontinued operations.
  • Worldwide realized oil price averaged $58.99 per barrel versus an average WTI index price of $59.14; worldwide realized natural gas averaged $1.29 per Mcf versus a NYMEX index price of $3.61.
  • Average diluted shares outstanding for the fourth quarter of 2025 were 1,002.9 million.

The filing

CompanyOccidental Petroleum (OXY)
Form8-K, current report
Filed with the SECJan 20, 2026, 7:00 AM ET
Accession number0001628280-26-002483

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.